
Journal Basic Info
**Impact Factor calculated based on Google Scholar Citations. Please contact us for any more details.Major Scope
- Chemoprevention
- Colon Cancer
- Gastrointestinal Cancer
- Ovarian Cancer
- Melanoma/Skin Cancer
- Carcinomas
- Paediatric Cancers
- Radiation Therapy
Abstract
Citation: Clin Oncol. 2021;6(1):1853.DOI: 10.25107/2474-1663.1853
Clinically Amyopathic Paraneoplastic Dermatomyositis, Secondary to Breast Cancer
Gustavo Moreira Amorim, Ingrid Reuwsaat Paul, Clio Nicolacópulos, Bruna Molozzi, Gabriella Di Giunta Funchal and Timotio Volnei Dorn
Sector of Dermatology, Hospital Santa Teresa, Brazil
South Santa Catarina University, Brazil
Federal University of Rio de Janeiro, Brazil
Sector of Dermatology and Pathology, Federal University of Santa Catarina, Campus Florianópolis, Brazil
*Correspondance to: Gustavo Moreira Amorim
PDF Full Text Case Report | Open Access
Abstract:
Dermatomyositis (DM) is an idiopathic inflammatory disease that affects the skin, striated muscles, and other organs. About 20% of the cases correspond to Clinically Amyopathic Dermatomyositis (CADM), a subgroup of DM. This consists of characteristic skin findings of DM, but without myopathic associate1. In both situations, 20% to 30% are associated with malignancy, especially with
ovarian, breast and lung cancer. This case report aims to emphasize the importance of being familiar with the clinical presentation of the disease and the significant association with malignancies, once early diagnosis reduces patient mortality.
Keywords:
Dermatomyositis; Myositis; Idiopathic inflammatory myopathy; Malignance
Cite the Article:
Amorim GM, Paul IR, Nicolacópulos C, Molozzi B, Di Giunta Funchal G, Dorn TV. Clinically Amyopathic Paraneoplastic Dermatomyositis, Secondary to Breast Cancer. Clin Oncol. 2021;6:1853..